Spyre Therapeutics (SYRE) Stock Chart & Stock Price History $29.20 -2.07 (-6.62%) (As of 11/15/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Spyre Therapeutics Stock Price Performance 5 Day Performance-18.48%1 Month Performance-10.87%3 Month Performance+12.14%6 Month Performance-22.75%Year-To-Date Performance+35.69% Receive SYRE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Spyre Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover SYRE Stock Chart for Sunday, November, 17, 2024 SYRE Chart by TradingView Spyre Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/15/2024$31.27$29.20-6.62%$31.35$29.14394,556 shs$1.50 billion11/14/2024$32.98$31.27-5.18%$33.47$31.16359,333 shs$1.61 billion11/13/2024$35.82$32.98-7.93%$36.98$32.23793,597 shs$1.70 billion11/12/2024$39.35$35.82-8.97%$40.26$35.421.22 million shs$1.82 billion11/11/2024$39.58$39.35-0.57%$40.09$38.61537,407 shs$2.00 billion11/08/2024$37.69$39.58+5.00%$39.63$33.00428,878 shs$2.02 billion Get the Latest News and Ratings for SYRE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Spyre Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/07/2024$37.48$37.69+0.56%$38.73$36.92641,118 shs$1.92 billion11/06/2024$35.92$37.48+4.34%$38.05$35.91545,507 shs$1.91 billion11/05/2024$35.13$35.92+2.25%$36.08$34.68326,564 shs$1.83 billion11/04/2024$33.98$35.13+3.38%$35.46$33.10383,221 shs$1.79 billion11/01/2024$32.53$33.98+4.46%$34.13$32.72387,770 shs$1.73 billion10/31/2024$34.16$32.53-4.77%$34.32$32.24363,658 shs$1.66 billion10/30/2024$33.80$34.16+1.07%$34.91$33.51268,239 shs$1.74 billion10/29/2024$34.40$33.80-1.74%$34.70$32.91312,090 shs$1.72 billion10/28/2024$34.81$34.40-1.18%$36.09$34.29230,308 shs$1.39 billion10/25/2024$33.70$34.81+3.29%$36.60$34.14537,120 shs$1.40 billion10/24/2024$33.61$33.70+0.27%$34.46$33.37229,757 shs$1.36 billion10/23/2024$34.15$33.61-1.58%$34.70$32.22591,691 shs$1.35 billion10/22/2024$32.43$34.15+5.30%$34.21$32.19394,008 shs$1.38 billion10/21/2024$32.76$32.43-1.01%$33.14$31.70197,698 shs$1.31 billion10/18/2024$32.76$32.76$33.26$31.89212,707 shs$1.32 billion10/17/2024$32.37$32.76+1.20%$34.14$32.17605,695 shs$1.32 billion10/16/2024$31.48$32.37+2.83%$32.45$30.61438,458 shs$1.30 billion Related Companies ELAN Stock Chart VKTX Stock Chart CYTK Stock Chart BPMC Stock Chart LNTH Stock Chart NUVL Stock Chart RNA Stock Chart ACLX Stock Chart KRYS Stock Chart ADMA Stock Chart Receive SYRE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Spyre Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SYRE) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spyre Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Spyre Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
